Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 3, 2012, Pages 254-260

  Eickhoff, Christiane ^a   Hämmerlein, Andrea ^a   Griese, Nina ^a   Schulz, Martin ^a  

^a ABDA Federal Union of German Associations of Pharmacists   (Germany)

Author keywords

Community pharmacy; Drug related problems; Frequency; OTC drug use; Pharmacy practice; Self medication

Indexed keywords

NON PRESCRIPTION DRUG;

ARTICLE; COMMUNITY; DOCUMENTATION; DRUG INDICATION; DRUG SUBSTITUTION; DRUG USE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PATIENT REFERRAL; PHARMACIST; PHARMACY; PRIORITY JOURNAL; SELF MEDICATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COMMUNITY PHARMACY SERVICES; DRUG TOXICITY; GERMANY; HUMANS; NONPRESCRIPTION DRUGS; PHARMACISTS; PROFESSIONAL ROLE; SELF MEDICATION;

EID: 84858293822     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2241     Document Type: Article

References (39)

1. Blenkinsopp A, Bradley C. Patients, society, and the increase in self medication. BMJ 1996; 312(7031): 629-632.
2. Eickhoff C, Schulz M. Pharmaceutical care in community pharmacies: practice and research in Germany. Ann Pharmacother 2006; 40(4): 729-735.
3. Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001; 345(11): 810-816.
4. Bond C, Hannaford P. Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Saf 2003; 26(15): 1065-1074.
5. Clark D, Layton D, Shakir SA. Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports. BMJ 2001; 323(7315): 706-707.
6. Roumie CL, Griffin MR. Over-the-counter analgesics in older adults: a call for improved labelling and consumer education. Drugs Aging 2004; 21(8): 485-498.
7. Martin-Facklam M, Rieger K, Riedel KD, Burhenne J, Walter-Sack I, Haefeli WE. Undeclared exposure to St. John's Wort in hospitalized patients. Br J Clin Pharmacol 2004; 58(4): 437-441.
8. Bednar B. OTC medication-induced nephrotoxicity in the elderly and CKD patient. Nephrol News Issues 2009; 23(8): 36, 38-40, 43-44.
9. Charupatanapong N. Perceived likelihood of risks in self-medication practices. J Soc Admin Pharm 1994; 11: 18-28.
10. Du Y, Knopf H. Self-medication among children and adolescents in Germany: results of the National Health Survey for Children and Adolescents (KiGGS). Br J Clin Pharmacol 2009; 68(4): 599-608.
11. Farker K, Rottenkolber M, Drewelow B, et al. Patient self-medication and serious adverse drug reactions (ADRs). Br J Clin Pharmacol 2009; 68 (Suppl. 1): 56.
12. Ferner RE, Beard K. Over the counter medicines: proceed with caution. BMJ 2008; 336(7646): 694-696.
13. Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci 2008; 30(6): 854-862.
14. Lessenger JE, Feinberg SD. Abuse of prescription and over-the-counter medications. J Am Board Fam Med 2008; 21(1): 45-54.
15. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008; 300(24): 2867-2878.
16. Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar--pediatric cough and cold medications. N Engl J Med 2007; 357(23): 2321-2324.
17. Sihvo S, Klaukka T, Martikainen J, Hemminki E. Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. Eur J Clin Pharmacol 2000; 56(6-7): 495-499.
18. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001; 41(2): 192-199.
19. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995; 155(18): 1949-1956.
20. Andersson AC, Brodin H, Nilsson JLG. Pharmacist interventions in relation to patient drug-related problems. J Soc Admin Pharm 2003; 20(3): 82-91.
21. Eichenberger PM, Lampert ML, Kahmann IV, van Mil JW, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci 2010; 32(3): 362-372.
22. Hämmerlein A, Griese N, Schulz M. Survey of drug-related problems identified by community pharmacies. Ann Pharmacother 2007; 41(11): 1825-1832.
23. Lewinski D, Wind S, Belgardt C, Plate V, Behles C, Schweim HG. Prevalence and safety-relevance of drug-related problems in German community pharmacies. Pharmacoepidemiol Drug Saf 2010; 19(2): 141-149.
24. Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care 1992; 30(10): 926-940.
25. van Mil JW, Dudok van Heel MC, Boersma M, Tromp TF. Interventions and documentation for drug-related problems in Dutch community pharmacies. Am J Health Syst Pharm 2001; 58(15): 1428-1431.
26. Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999; 21(6): 245-250.
27. Westerlund T, Almarsdottir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract 1999; 7: 40-50.
28. Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther 2009; 34(3): 319-327.
29. Pharmaceutical Care Network Europe (PCNE). The PCNE Classification V6.2, 2010. [15 July 2011].
30. Westerlund LT, Marklund BR, Handl WH, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother 2001; 35(11): 1343-1349.
31. ABDA-Federal Union of German Associations of Pharmacists. German Pharmacies: Figures, Data, Facts 2007, 2005.
32. ABDA-Federal Union of German Associations of Pharmacists. ABDA standard on good counseling practice, 2006.
33. WHO Collaborating Centre for Drug Statistics Methodology O. Guidelines for ATC classification and DDD assignment, 2003.
34. National Council on Patient Information and Education. Attitudes and beliefs about the use of over-the-counter medications: A dose of reality: a national survey of consumers and health professionals, 2002.
35. National Council on Patient Information and Education. Uses and attitudes about taking over-the-counter medicines: Findings of a 2003 national opinion survey, 2003.
36. Peterson GM. Selecting nonprescription analgesics. Am J Ther 2005; 12(1): 67-79.
37. Benrimoj SI, Langford JH, Berry G, et al. Clinical intervention rates in community pharmacy: A randomised trial of the effect of education and a professional allowance. Int J Pharm Pract 2003; 11: 71-80.
38. Poston J, Kennedy R, Waruszynski B. Initial results from the community pharmacist intervention study. Can Pharm J 1995; 127: 18-24.
39. Ax F, Branstad J-O, Westerlund T. Pharmacy counselling models: a means to improve drug use. J Clin Pharm Ther 2010; 35: 439-451.